These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35605642)

  • 21. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
    Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
    Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry.
    Vittonatto E; Boschi S; CHIADò-Piat L; Ponzalino V; Bortolani S; Brusa C; Rainero I; Ricci F; Vercelli L; Mongini T
    Acta Myol; 2017 Dec; 36(4):191-198. PubMed ID: 29770361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.
    Vanherpe P; Fieuws S; D'Hondt A; Bleyenheuft C; Demaerel P; De Bleecker J; Van den Bergh P; Baets J; Remiche G; Verhoeven K; Delstanche S; Toussaint M; Buyse B; Van Damme P; Depuydt CE; Claeys KG
    Orphanet J Rare Dis; 2020 Apr; 15(1):83. PubMed ID: 32248831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
    Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
    Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China.
    Zhao HH; Ma Z; Ying ZX; Niu FN; Luo MT; Wang Z; Cheng X; Zhang QQ; Niu Q
    Ann Transl Med; 2021 Dec; 9(24):1803. PubMed ID: 35071497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decoding the muscle transcriptome of patients with late onset Pompe disease reveals markers of disease progression.
    Monceau A; Gokul Nath R; Suárez-Calvet X; Musumeci O; Toscano A; Kierdaszuk B; Kostera-Pruszczyk A; Domínguez-González C; Hernández-Lain A; Paradas C; Rivas E; Papadimas G; Papadopoulos C; Chrysanthou-Piterou M; Gallardo E; Olivé M; Lilleker J; Roberts ME; Marchese D; Lunazzi G; Heyn H; Fernández-Simón E; Villalobos E; Clark J; Katsikis P; Collins C; Mehra P; Laidler Z; Vincent A; Tasca G; Marini-Bettolo C; Guglieri M; Straub V; Raben N; Díaz-Manera J
    Brain; 2024 Jul; ():. PubMed ID: 39045638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.
    Pallafacchina G; Calabria E; Serrano AL; Kalhovde JM; Schiaffino S
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9213-8. PubMed ID: 12084817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
    Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
    Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Cobalt Chloride, a Hypoxia-Mimetic Agent, on Autophagy and Atrophy in Skeletal C2C12 Myotubes.
    Chen R; Jiang T; She Y; Xu J; Li C; Zhou S; Shen H; Shi H; Liu S
    Biomed Res Int; 2017; 2017():7097580. PubMed ID: 28706950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
    Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
    Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter lesions in treated late onset Pompe disease are not different to matched controls.
    Schneider I; Hensel O; Zierz S
    Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
    Golsari A; Nasimzadah A; Thomalla G; Keller S; Gerloff C; Magnus T
    Neuromuscul Disord; 2018 Mar; 28(3):257-261. PubMed ID: 29326002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
    Montagnese F; Barca E; Musumeci O; Mondello S; Migliorato A; Ciranni A; Rodolico C; De Filippi P; Danesino C; Toscano A
    J Neurol; 2015; 262(4):968-78. PubMed ID: 25673129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
    Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
    Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype.
    van den Berg LE; Drost MR; Schaart G; de Laat J; van Doorn PA; van der Ploeg AT; Reuser AJ
    J Inherit Metab Dis; 2013 Sep; 36(5):787-94. PubMed ID: 23053471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oleamide rescues tibialis anterior muscle atrophy of mice housed in small cages.
    Kobayashi Y; Watanabe N; Kitakaze T; Sugimoto K; Izawa T; Kai K; Harada N; Yamaji R
    Br J Nutr; 2021 Aug; 126(4):481-491. PubMed ID: 33143796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BST204, a Rg3 and Rh2 Enriched Ginseng Extract, Upregulates Myotube Formation and Mitochondrial Function in TNF-α-Induced Atrophic Myotubes.
    Lee SJ; Im M; Park SK; Kim JY; So EY; Liang OD; Kang JS; Bae GU
    Am J Chin Med; 2020; 48(3):631-650. PubMed ID: 32329640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.
    Takahashi J; Mori-Yoshimura M; Ariga H; Sato N; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2022; 9(5):619-627. PubMed ID: 35964201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
    Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
    Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.